Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
Titel:
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
Auteur:
du Bois, Andreas Kristensen, Gunnar Ray-Coquard, Isabelle Reuss, Alexander Pignata, Sandro Colombo, Nicoletta Denison, Ursula Vergote, Ignace del Campo, Jose M Ottevanger, Petronella Heubner, Martin Minarik, Thomas Sevin, Emmanuel de Gregorio, Nikolaus Bidziński, Mariusz Pfisterer, Jacobus Malander, Susanne Hilpert, Felix Mirza, Mansoor R Scambia, Giovanni Meier, Werner Nicoletto, Maria O Bjørge, Line Lortholary, Alain Sailer, Martin Oliver Merger, Michael Harter, Philipp